Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro

BACKGROUND: We examined the association of tumor-derived hepatocyte growth factor (HGF) with the clinicopathological features of gliomas and investigated the effect of HGF inhibition on the biological behavior of tumor cells in vitro in order to determine whether HGF is a valuable prognostic predict...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Guo, You-feng, Wang, Xiao-bing, Tian, Xiao-ying, Li, Yang, Li, Bin, Huang, Quan, Zhang, Meng, Li, Zhi
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3447698/
https://ncbi.nlm.nih.gov/pubmed/22741575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-10-128
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars